Viewing nowCitrica Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
HLB Pharmaceuticals Co., Ltd.

MFDS item code 201902047 · Approved 2019.04.04 · Insurance code 647303750
Treatment of peripheral and central neuropathic pain, adjunctive treatment for partial seizures in epilepsy, improvement of fibromyalgia
This medication is used to effectively treat peripheral and central neuropathic pain in adults. It is also used as an adjunctive therapy alongside primary medication for patients with epilepsy who exhibit partial seizures. Additionally, it is helpful in alleviating pain for patients with fibromyalgia. Overall, it is effective for neuropathic pain and seizure disorders, contributing to the improvement of symptoms in patients.
This medication is pregabalin and should be taken orally without regard to food, divided into two doses per day. 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose is 150 mg per day, and it can be increased to 300 mg per day after 3 to 7 days. If necessary, it can be further increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain Adults:
There is insufficient safety and efficacy data for pediatric patients under 12 years and adolescents aged 12 to 17 years, hence administration is not recommended.
This medication may increase the risk of suicidal thoughts or actions, so mood changes or symptoms of depression should be carefully monitored during treatment. Patients with hypersensitivity to this medication or specific genetic issues such as lactose intolerance should not use it. Diabetic patients should be cautious as weight gain may require adjustments in glycemic control medications. If symptoms of angioedema occur, this medication should be discontinued immediately. Elderly patients experiencing severe dizziness or drowsiness may be at risk of falls and should take caution. Blurred vision or changes in vision may improve upon discontinuation of this medication. Abrupt withdrawal may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually in consultation with a healthcare professional. Patients with a history of drug abuse should take special care due to the risk of abuse associated with this medication. Dose adjustments may be necessary for patients with impaired renal function. Patients with heart disease should exercise caution while taking this medication, and concurrent use with opioid analgesics increases the risk of central nervous system depression. Patients with compromised respiratory function or the elderly may be at risk of severe respiratory depression, making dose adjustments necessary. Pregnant women should avoid this medication during early pregnancy due to the potential risk of fetal malformation, and women of childbearing age should use effective contraception. Breastfeeding women should consider stopping breastfeeding or discontinuing this medication, as it can be passed into breast milk. Dizziness or drowsiness may occur when driving or operating machinery, necessitating caution until symptoms have completely resolved. Severe skin reactions can occur, so if symptoms such as skin rash or swelling arise, the medication should be discontinued immediately and medical advice sought. Overdose may result in mental confusion, drowsiness, depression, and seizures, requiring immediate medical attention, and blood dialysis may be necessary if required. This medication may require dose adjustments for special populations such as children or the elderly, and it should be taken as directed by a healthcare professional. This medication has minimal drug interactions, but the risk of side effects increases when taken with central nervous system depressants, so it is imperative to inform healthcare professionals of all medications being taken.
Hives, severe swelling (angioedema, facial swelling, oral and upper airway swelling), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice)
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 15 to 30 degrees Celsius.
A hard capsule with a white upper part and a white lower part containing a powder that is white to light yellow in color
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
HLB Pharmaceuticals Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.